Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane proteins and other cellular macromolecules represent a broad and non-specific group of targets for various antimicrobial agents, particularly antiseptics and disinfectants. These targets include a wide array of essential components such as structural proteins in the cell wall and plasma membrane, enzymes involved in metabolic pathways, and genetic material like DNA and RNA. By interacting with these diverse molecules, antimicrobial agents can cause protein denaturation, membrane leakage, and inhibition of vital cellular functions, leading to bacterial cell death. This multi-target approach is characteristic of broad-spectrum biocides, which often exhibit a lower risk of rapid resistance development compared to site-specific antibiotics. However, the lack of specificity can also lead to potential toxicity in host tissues if the agent is not used appropriately.
Non-specific binding and denaturation of proteins, disruption of cell membrane integrity, and interference with metabolic processes and nucleic acid function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial membrane proteins and other cellular macromolecules.